Malabsorption is a major contributor to underweight in Crohn's disease patients in remission

被引:55
|
作者
Vaisman, Nachum [1 ]
Dotan, Iris
Halack, Aharon
Niv, Eva
机构
[1] Tel Aviv Univ, Sackler Fac Med, Unit Clin Nutr, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Inflammatory Bowel Dis Serv, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Dept Gastroenterol & Liver Dis, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
关键词
Crohn's disease; resting energy expenditure; malabsorption;
D O I
10.1016/j.nut.2006.05.013
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: Undernutrition has been reported in 65-75% of patients with Crohn's disease. The present study aimed at identifying the relative contribution of malnutrition-causing factors in patients with Crohn's disease in remission. Methods: Sixteen patients with Crohn's disease (age 19-57 y) in remission (Crohn's Activity Disease Index < 150) were included in the study. Their weight was stable for > 3 mo and they were off steroids. They all completed 3-d food records and concomitantly collected stools. Self-reported food records were analyzed and energy content in stools was determined by a direct bomb calorimeter. Resting energy expenditure (REE) was studied by indirect calorimetry and body composition by dual-energy X-ray absorptiometry. The study cohort was divided into two groups, with a body mass index (BMI) equal to 18.5 kg/m(2) serving as a cutoff point. Results: Subjects with lower BMIs tended to have less lean body mass (P = 0.006), less bone mineral density (P = 0.006), and lower REE (P = 0.003). No correlation was found between BMI and energy intake but the percentage of malabsorption was negatively correlated with BMI (P 0.07). When dividing the study based on a BMI of 18.5 kg/m(2), no difference was found in caloric intake or REE between groups but subjects with lower BMIs had significant prominent malabsorption compared with the others (21.1 +/- 9.8% versus 11.7 +/- 3.5%, P = 0.015). Conclusion: In the presence of similar energy intake, REE does not seem to contribute to lower BMI, although nutrient malabsorption is higher in malnourished patients with Crohn's disease in remission. We suggest that malabsorption be evaluated in patients with Crohn's disease who fail to gain weight during disease remission to establish their extra caloric requirements. (c) 2006 Elsevier Inc. All tights reserved.
引用
收藏
页码:855 / 859
页数:5
相关论文
共 50 条
  • [41] Budesonide for induction of remission in Crohn's disease
    Otley, A.
    Steinhart, A. H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (04):
  • [42] Adatimurnab for induction of remission Crohn's disease
    Abbass, Mohamad
    Cepek, Jeremy
    Parker, Claire E.
    Nguyen, Tran M.
    MacDonald, John K.
    Feagan, Brian G.
    Khanna, Reena
    Jairath, Vipul
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (11):
  • [43] Evolving Definitions of Remission in Crohn's Disease
    Panaccione, Remo
    Colombel, Jean-Frederic
    Louis, Edouard
    Peyrin-Biroulet, Laurent
    Sandborn, William J.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (08) : 1645 - 1653
  • [44] Glutamine for induction of remission in Crohn's disease
    Akobeng, Anthony K.
    Elawad, Mamoun
    Gordon, Morris
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [45] Methotrexate for maintenance of remission in Crohn's disease
    Patel, Vishal
    Wang, Yongjun
    MacDonald, John K.
    McDonald, John W. D.
    Chande, Nilesh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [46] Budesonide for maintenance of remission in Crohn's disease
    Benchimol, Eric I.
    Seow, Cynthia H.
    Otley, Anthony R.
    Steinhart, A. Hillary
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [47] Probiotics for induction of remission in Crohn's disease
    Limketkai, Berkeley N.
    Akobeng, Anthony K.
    Gordon, Morris
    Adepoju, Akinlolu Adedayo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (07):
  • [48] Natalizumab for induction of remission in Crohn's disease
    MacDonald, J. K.
    McDonald, J. W. D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):
  • [49] Natalizumab for induction of remission in Crohn's disease
    MacDonald, J. K.
    McDonald, J. W. D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03):
  • [50] Natalizumab for induction of remission in Crohn's disease
    Nelson, Seana M. L.
    Nguyen, Tran M.
    McDonald, John W. D.
    MacDonald, John K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):